Researchers conducted a retrospective, observational study in Glasgow between January 2010 and December 2013. They studied 12,000 blood cultures, of which 127 were deemed clinically significant.
The study shows the rate of inactive antimicrobial therapy was 47 percent. Patients who received antibiotics within the first 24 hours of being admitted to the ICU had lower mortality rates.
While severity of sepsis illness increased mortality, inactive antimicrobial therapy did not increase mortality or length of hospital stay. Additionally, researchers identified fungal bloodstream infection as a risk factor for receiving inactive antimicrobial therapy.
More articles on healthcare quality:
Study: Ability to anticipate falls weakens with age
National Quality Forum creates the Health Equity Program
Texas’ largest nursing home operator in hot water for Hurricane Harvey response
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.